EUVIMEDEUVIMED entdecken
Crossref

Safety of Endoscopic Ultrasound-guided choledocho-duodenostomy in patients with malignant obstruction and ascites

A. Kulkarni, S. Mukewar, B. Bhaware, A. Daphale, A. Patel, S. Mukewar

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S247

DOI: 10.1055/s-0044-1783265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von A. Kulkarni und 5 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate the safety of endoscopic ultrasound-guided choledocho-duodenostomy (EUS-CDS) in malignant biliary obstruction (MBO) and ascites in a restrospective study.

Methods

Prospectively maintained records of patients with MBO and ascites were retrospectively reviewed. Forty-four patients required EUS-CDS due to failed ERCP (28 males, 16 females). Forty-three underwent EUS-CDS, while one underwent a choledocho-gastrostomy. The data were reviewed for immediate postoperative complications (abdominal pain, fever, increase in ascites, bile leak) and technical success (defined as successful stent deployment).

Results

The most common lesions were pancreatic cancer (22), ampullary cancer (9), and duodenal cancer (5). Four had distal cholangiocarcinoma, two revealed malignant lymph nodal metastases causing MBO, and one each had gastric cancer and gall bladder cancer. Ten patients (22.7%) had ascites in the pre-procedure imaging (six had grade I ascites, and two had grade II and III ascites each). Technical success was achieved in all patients. Only two patients with ascites had bile leak, and one patient had fever responsive to antibiotics. In the group without ascites before the procedure, one had bile leak. The incidence of major adverse events was comparable across the two groups (p=0.53).

Conclusions

We hereby present the data to prove that EUS-CDS is safe in patients with MBO and ascites. Previously, EUS-guided drainage is generally presumed to be contra-indicated in the presence of ascites [ 1 ]. EUS-hepaticogastrostomy has been shown to be safe in the presence of ascites [ 2 ]. Further larger studies are needed to evaluate the long-term safety data of EUS-guided drainage and the effect on the survival of these patients. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Kulkarni, A., Mukewar, S., Bhaware, B., Daphale, A., Patel, A., & Mukewar, S. (2024). Safety of Endoscopic Ultrasound-guided choledocho-duodenostomy in patients with malignant obstruction and ascites. Endoscopy, 56(S 02 S 02), S247. https://doi.org/10.1055/s-0044-1783265

Vancouver

Kulkarni A, Mukewar S, Bhaware B, Daphale A, Patel A, Mukewar S. Safety of Endoscopic Ultrasound-guided choledocho-duodenostomy in patients with malignant obstruction and ascites. Endoscopy. 2024;56(S 02 S 02):S247. doi:10.1055/s-0044-1783265

BibTeX
@article{Kulkarni2024,
  author = {Kulkarni, A. and Mukewar, S. and Bhaware, B. and Daphale, A. and Patel, A. and Mukewar, S.},
  title = {Safety of Endoscopic Ultrasound-guided choledocho-duodenostomy in patients with malignant obstruction and ascites},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S247},
  doi = {10.1055/s-0044-1783265}
}
Kostenlos starten →